Pharmala Biotech Holdings Inc.

C$0.15As of Sun 8 Nov 2026, 12:00 UTC
CSE:MDMAHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR 21.18%
Div yield —
ROE (68.66%)
Biotechnology
Beta (5Y) 0.87
PE TTM —
TSR TTM 20.00%
Mkt cap C$16.45M
ROIC (37.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.185
23.63%
(59.83%)
Hold 6|7|1|3|6
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
37.74%
34.81%
40.04%
26.50%
Revenue$M
0.838
0.855
0.844
0.869
5.94%
5.06%
5.08%
3.24%
Peers (US$12.42M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.442
0.547
0.426
EBIT/Intx
0.390
0.257
0.256
Own earn%
134.42
81.96
93.28
Sh yield%
39.38
13.62
14.03
Owners
Insiders/Inst%
3.78
25.54
Short interest%
1.86
SBC / revenue%
4.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
17–24
$1 testx
—
Incr. ROIC%
14